This activity is part 2 in a 3-part webinar curriculum.
Program Description
Specialty pharmacists can help enhance and provide education of age-related macular degeneration (AMD) and diabetic macular edema (DME) to combat nonadherence. To improve outcomes, pharmacists can account for patient preference for medications when incorporating new and emerging agents in treatment approaches. As medication experts, pharmacists should be knowledgeable of the current treatment strategies and options to optimize therapy for AMD and DME and provide individualized care to patients. This second webinar in a 3-part series of the curriculum will explore the role of the pharmacist in the management of AMD and DME, as well as the significance of recent treatment advances to patient care.
Target audience: Specialty pharmacists
Type of activity: Application
Release date: August 30, 2023
Expiration date: August 30, 2024
Time to complete activity: 1.0 hour
Learner level: Foundational, Intermediate
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Examine age-related macular degeneration (AMD) and diabetic macular edema (DME) treatment guidelines and the challenges with traditional therapies
- Investigate the mechanisms of action of the anti-vascular endothelial growth factor therapies used to manage AMD and DME
- Analyze the clinical safety and efficacy of new and emerging therapies and their role in the AMD and DME treatment landscape
Elsen Jacob, PharmD, MS, BCPS, BCGP, CPPS
Assistant Professor, Department of Clinical Health Professions
St John’s University College of Pharmacy & Health Sciences
Clinical Coordinator, Department of Pharmacy
Inpatient Clinical Pharmacy Faculty
Family Medicine and Pharmacy Residency Programs
The Mount Sinai Hospital
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-23-347-H01-P. The activity is available for CE credit through August 30, 2024.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
Elsen Jacob, PharmD, MS, BCPS, BCGP, CPPS
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Michelle C. Carlson, PharmD; Abigail Dill, Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green.
Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms